TGLVY
Price
$1.06
Change
+$0.11 (+11.58%)
Updated
Dec 12 closing price
VPTDF
Price
$0.07
Change
+$0.01 (+16.67%)
Updated
Dec 18 closing price
Ad is loading...

TGLVY vs VPTDF

Header iconTGLVY vs VPTDF Comparison
Open Charts TGLVY vs VPTDFBanner chart's image
Top Glove
Price$1.06
Change+$0.11 (+11.58%)
Volume$1K
CapitalizationN/A
VentriPoint Diagnostics
Price$0.07
Change+$0.01 (+16.67%)
Volume$303.28K
CapitalizationN/A
TGLVY vs VPTDF Comparison Chart
Loading...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TGLVY vs. VPTDF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGLVY is a Buy and VPTDF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (TGLVY: $1.06 vs. VPTDF: $0.06)
Brand notoriety: TGLVY and VPTDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TGLVY: 51% vs. VPTDF: 183%
Market capitalization -- TGLVY: $1.65B vs. VPTDF: $35.49M
TGLVY [@Medical Specialties] is valued at $1.65B. VPTDF’s [@Medical Specialties] market capitalization is $35.49M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGLVY’s FA Score shows that 2 FA rating(s) are green whileVPTDF’s FA Score has 0 green FA rating(s).

  • TGLVY’s FA Score: 2 green, 3 red.
  • VPTDF’s FA Score: 0 green, 5 red.
According to our system of comparison, TGLVY is a better buy in the long-term than VPTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGLVY’s TA Score shows that 7 TA indicator(s) are bullish while VPTDF’s TA Score has 4 bullish TA indicator(s).

  • TGLVY’s TA Score: 7 bullish, 3 bearish.
  • VPTDF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TGLVY is a better buy in the short-term than VPTDF.

Price Growth

TGLVY (@Medical Specialties) experienced а +11.57% price change this week, while VPTDF (@Medical Specialties) price change was -14.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.17%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was -0.66%.

Industries' Descriptions

@Medical Specialties (-4.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGLVY($1.65B) has a higher market cap than VPTDF($35.5M). TGLVY YTD gains are higher at: 51.429 vs. VPTDF (-68.710). VPTDF has higher annual earnings (EBITDA): -5.14M vs. TGLVY (-122.26M). TGLVY has more cash in the bank: 988M vs. VPTDF (4.28M). VPTDF has less debt than TGLVY: VPTDF (459K) vs TGLVY (654M). TGLVY has higher revenues than VPTDF: TGLVY (2.77B) vs VPTDF (47.5K).
TGLVYVPTDFTGLVY / VPTDF
Capitalization1.65B35.5M4,654%
EBITDA-122.26M-5.14M2,378%
Gain YTD51.429-68.710-75%
P/E Ratio27.25N/A-
Revenue2.77B47.5K5,833,684%
Total Cash988M4.28M23,111%
Total Debt654M459K142,484%
FUNDAMENTALS RATINGS
TGLVY vs VPTDF: Fundamental Ratings
TGLVY
VPTDF
OUTLOOK RATING
1..100
2969
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
4396
P/E GROWTH RATING
1..100
287
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGLVY's Valuation (11) in the null industry is significantly better than the same rating for VPTDF (99). This means that TGLVY’s stock grew significantly faster than VPTDF’s over the last 12 months.

TGLVY's Profit vs Risk Rating (100) in the null industry is in the same range as VPTDF (100). This means that TGLVY’s stock grew similarly to VPTDF’s over the last 12 months.

TGLVY's SMR Rating (91) in the null industry is in the same range as VPTDF (100). This means that TGLVY’s stock grew similarly to VPTDF’s over the last 12 months.

TGLVY's Price Growth Rating (43) in the null industry is somewhat better than the same rating for VPTDF (96). This means that TGLVY’s stock grew somewhat faster than VPTDF’s over the last 12 months.

TGLVY's P/E Growth Rating (2) in the null industry is significantly better than the same rating for VPTDF (87). This means that TGLVY’s stock grew significantly faster than VPTDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGLVYVPTDF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 9 days ago
68%
Declines
ODDS (%)
Bearish Trend 23 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSMD29.09N/A
-0.01%
Pacer Swan SOS Moderate (January) ETF
BSMP24.52-0.06
-0.24%
Invesco BulletShares 2025 Muncpl Bd ETF
GEM32.80-0.78
-2.32%
Goldman Sachs ActiveBeta® EMkts Eq ETF
SPMD54.67-2.21
-3.89%
SPDR® Portfolio S&P 400™ Mid Cap ETF
IWML21.24-2.26
-9.61%
ETRACS 2x Leveraged US Size Fctr TR ETN

TGLVY and

Correlation & Price change

A.I.dvisor tells us that TGLVY and BNR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and BNR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGLVY
1D Price
Change %
TGLVY100%
N/A
BNR - TGLVY
20%
Poorly correlated
+4.17%
TRXO - TGLVY
13%
Poorly correlated
N/A
SSMXY - TGLVY
12%
Poorly correlated
-2.34%
VPTDF - TGLVY
8%
Poorly correlated
+13.33%
TRUMY - TGLVY
3%
Poorly correlated
-3.07%
More

VPTDF and

Correlation & Price change

A.I.dvisor tells us that VPTDF and TWST have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VPTDF and TWST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VPTDF
1D Price
Change %
VPTDF100%
+13.33%
TWST - VPTDF
21%
Poorly correlated
-7.83%
OM - VPTDF
14%
Poorly correlated
+0.99%
TLTFF - VPTDF
13%
Poorly correlated
+4.11%
TGLVY - VPTDF
8%
Poorly correlated
N/A
WILYY - VPTDF
7%
Poorly correlated
N/A
More